Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$15.39 - $18.97 $2,477 - $3,054
-161 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$14.59 - $19.5 $145 - $195
-10 Reduced 5.85%
161 $3,000
Q4 2019

Feb 14, 2020

BUY
$16.88 - $20.83 $2,717 - $3,353
161 Added 1610.0%
171 $3,000
Q3 2019

Nov 15, 2019

SELL
$16.15 - $17.99 $63,647 - $70,898
-3,941 Reduced 99.75%
10 $0
Q1 2019

Jul 15, 2019

BUY
$16.7 - $21.52 $65,981 - $85,025
3,951 New
3,951 $80,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.